Finally, we applied this BRCA1-specific and the previously published BRCA2-specific models to predict the pathogenicity of variants of uncertain significance that were identified in patients with breast cancer by the Qatari National Center of Cancer Care and Research. This evidence concerns the gene BRCA1 and breast carcinoma.